» Authors » Tom Maishman

Tom Maishman

Explore the profile of Tom Maishman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 2536
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ndodo N, Ashcroft J, Lewandowski K, Yinka-Ogunleye A, Chukwu C, Ahmad A, et al.
Nat Med . 2023 Sep; 29(9):2317-2324. PMID: 37710003
The 2022 global mpox outbreak raises questions about how this zoonotic disease established effective human-to-human transmission and its potential for further adaptation. The 2022 outbreak virus is related to an...
2.
Gallagher H, Dumbleton J, Maishman T, Whitehead A, Moore M, Fuat A, et al.
Trials . 2022 Apr; 23(1):331. PMID: 35449015
Background: Chronic kidney disease (CKD) is a very common long-term condition and powerful risk factor for cardiovascular disease (CVD). Low-dose aspirin is of proven benefit in the secondary prevention of...
3.
Greville-Heygate S, Maishman T, Tapper W, Cutress R, Copson E, Dunning A, et al.
JCO Precis Oncol . 2020 Sep; 4. PMID: 32923877
Purpose: Checkpoint kinase 2 () is frequently included in multigene panels. We describe the associated outcomes among carriers of pathogenic variants in young patients with symptomatic breast cancer. Patients And...
4.
Fenlon D, Maishman T, Day L, Nuttall J, May C, Ellis M, et al.
Psychooncology . 2020 May; 29(10):1514-1523. PMID: 32458473
Objective: Troublesome hot flushes and night sweats (HFNS) are experienced by many women after treatment for breast cancer, impacting significantly on sleep and quality of life. Cognitive behavioural therapy (CBT)...
5.
Mckenzie H, Maishman T, Simmonds P, Durcan L, Eccles D, Copson E
Br J Cancer . 2020 Apr; 122(11):1618-1629. PMID: 32231292
Background: It is not clear how the pathology, presentation and outcome for patients who present with de novo metastatic breast cancer (dnMBC) compare with those who later develop distant metastases....
6.
Bridgewater J, Pugh S, Maishman T, Eminton Z, Mellor J, Whitehead A, et al.
Lancet Oncol . 2020 Feb; 21(3):398-411. PMID: 32014119
Background: The interim analysis of the multicentre New EPOC trial in patients with resectable colorectal liver metastasis showed a significant reduction in progression-free survival in patients allocated to cetuximab plus...
7.
Mahmoudi M, Nicholas Z, Nuttall J, Bresser M, Maishman T, Berry C, et al.
Cardiovasc Revasc Med . 2020 Jan; 21(7):890-896. PMID: 31932171
Background: Fractional flow reserve measurement based on computed tomography (FFR) is a novel, well validated, non-invasive method for determining the presence and extent of coronary artery disease (CAD) combined with...
8.
Fachal L, Aschard H, Beesley J, Barnes D, Allen J, Kar S, et al.
Nat Genet . 2020 Jan; 52(1):56-73. PMID: 31911677
Genome-wide association studies have identified breast cancer risk variants in over 150 genomic regions, but the mechanisms underlying risk remain largely unknown. These regions were explored by combining association analysis...
9.
Bate J, Borrow R, Chisholm J, Clarke S, Dixon E, Faust S, et al.
Clin Infect Dis . 2019 Oct; 71(5):1271-1280. PMID: 31586206
Background: Children with acute lymphoblastic leukemia (ALL) are at increased risk of developing invasive pneumococcal disease. This study describes the immunogenicity of 13-valent pneumococcal conjugate vaccine (PCV13) during and after...
10.
Davies A, Cummin T, Barrans S, Maishman T, Mamot C, Novak U, et al.
Lancet Oncol . 2019 Apr; 20(5):649-662. PMID: 30948276
Background: Biologically distinct subtypes of diffuse large B-cell lymphoma can be identified using gene-expression analysis to determine their cell of origin, corresponding to germinal centre or activated B cell. We...